RPL31P14

Across TCGA pan-cancer cohorts, RPL31P14 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPL31P14 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL31P14 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL31P14 expression acts as an unfavorable survival marker, although some lineages such as LUSC and LGG show a favorable association.

KIRC, ESCA, and LUSC are the cancer types where RPL31P14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	All	0.814	0.892	.011	25	view →
ESCA	OS	Quartile	III,IV	0.248	0.618	.004	24	view →
LUSC	DFS	Quartile	All	0.497	0.304	.002	18	view →
STAD	OS	Median	II,III,IV	0.195	0.464	.005	15	view →
LGG	DFS	Tertile	All	0.650	0.346	.002	14	view →
BLCA	DFS	Tertile	IV	0.098	0.267	.034	9	view →
UVM	OS	Tertile	III,IV	0.220	0.872	.025	9	view →
DLBC	OS	Quartile	II,III,IV	0.430	0.842	.006	9	view →
LIHC	DFS	Tertile	III,IV	0.168	0.442	.025	9	view →
KICH	DFS	Tertile	All	0.628	0.942	.021	6	view →
THCA	OS	Tertile	IV	0.551	0.924	.006	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPL31P14–KIRC (DFS)

Open the KIRC breakdown →